<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: ldl</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Vitamin B niacin offers no extra benefit to statin therapy in seniors already diagnosed with CAD</title>
   	 <description>The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows.</description>
     <link>http://www.physorg.com/news177763973.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 18 Nov 2009 11:20:07 EST</pubDate>
	 <guid isPermaLink="false">news177763973</guid>
</item>
<item>
     <title>Prevalence of high LDL, or 'bad' cholesterol levels decreases in US</title>
   	 <description>Between 1999 and 2006, the prevalence of adults in the U.S. with high levels of LDL cholesterol, the "bad" cholesterol, decreased by about one-third, according to a study in the November 18 issue of JAMA. But a high percentage of adults still are not being screened or treated for high cholesterol levels. </description>
     <link>http://www.physorg.com/news177703506.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 17 Nov 2009 18:40:03 EST</pubDate>
	 <guid isPermaLink="false">news177703506</guid>
</item>
<item>
     <title>Early end to key study on benefits of niacin, a B vitamin, in keeping arteries open was premature</title>
   	 <description>Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing.  Cardiovascular atherosclerosis, as it is also known, is believed responsible for one in three deaths in the United States each year.</description>
     <link>http://www.physorg.com/news177592343.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 16 Nov 2009 11:14:09 EST</pubDate>
	 <guid isPermaLink="false">news177592343</guid>
</item>
<item>
     <title>Blood vessel bends and branches put the brakes on statins</title>
   	 <description>(PhysOrg.com) -- New British Heart Foundation (BHF) research revealed today suggests for the first time that the way blood flows through our arteries may boost an antioxidant effect of statin medicines. The discovery at Imperial College London is the first evidence of biomechanical forces affecting the action of a commonly- used drug, and could point the way towards new targets to improve artery health throughout the body.</description>
     <link>http://www.physorg.com/news166450261.html</link>
	 <category>Chemistry</category>
	 <pubDate>Fri, 10 Jul 2009 13:11:31 EST</pubDate>
	 <guid isPermaLink="false">news166450261</guid>
</item>
<item>
     <title>Newly discovered gene regulates balance of 'bad' cholesterol </title>
   	 <description>In an article in Science, Noam Zelcer from the LACDR (The Netherlands) describes a previously unknown mechanism for regulating the amount of LDL cholesterol. This offers opportunities for supplementing and improving the effect of so-called statins: medicines that remove 'bad' cholesterol from the bloodstream. </description>
     <link>http://www.physorg.com/news165739143.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 02 Jul 2009 07:39:41 EST</pubDate>
	 <guid isPermaLink="false">news165739143</guid>
</item>
<item>
     <title>Abbott, AstraZeneca seek cholesterol pill approval</title>
   	 <description>(AP) --  Abbott Laboratories and AstraZeneca PLC on Thursday asked the Food and Drug Administration to approve a drug that combines their cholesterol pills TriLipix and Crestor.</description>
     <link>http://www.physorg.com/news163335719.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 04 Jun 2009 12:02:24 EST</pubDate>
	 <guid isPermaLink="false">news163335719</guid>
</item>
<item>
     <title>Smoking, high blood pressure, being overweight -- top 3 preventable causes of death in the US</title>
   	 <description>Smoking, high blood pressure and being overweight are the leading preventable risk factors for premature mortality in the United States, according to a new study led by researchers at the Harvard School of Public Health (HSPH), with collaborators from the University of Toronto and the Institute for Health Metrics and Evaluation at the University of Washington. The researchers found that smoking is responsible for 467,000 premature deaths each year, high blood pressure for 395,000, and being overweight for 216,000. The effects of smoking work out to be about one in five deaths in American adults, while high blood pressure is responsible for one in six deaths.</description>
     <link>http://www.physorg.com/news160129857.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 28 Apr 2009 09:31:57 EST</pubDate>
	 <guid isPermaLink="false">news160129857</guid>
</item>
<item>
     <title>Combination of very low LDL and normal systolic blood pressure attenuate coronary artery disease</title>
   	 <description>New data published in the March 31, 2009, issue of the Journal of the American College of Cardiology show that patients with coronary artery disease (CAD) who achieve very low levels of low-density lipoprotein (LDL) cholesterol along with normal systolic blood pressure have the slowest progression of CAD. The results suggest that patients with CAD should be treated to the most stringent target levels so that they can achieve optimal results from their lipid lowering and antihypertensive therapies.</description>
     <link>http://www.physorg.com/news157048445.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 23 Mar 2009 17:34:38 EST</pubDate>
	 <guid isPermaLink="false">news157048445</guid>
</item>
<item>
     <title>Columbia research shows novel benefits of fatty acids in arteries</title>
   	 <description>New research from Columbia University Medical Center continues to shed light on the benefits of making fish a staple of any diet.</description>
     <link>http://www.physorg.com/news153073435.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 05 Feb 2009 16:24:37 EST</pubDate>
	 <guid isPermaLink="false">news153073435</guid>
</item>
<item>
     <title>Synthetic HDL: A new weapon to fight cholesterol problems</title>
   	 <description>Buttery Christmas cookies, eggnog, juicy beef roast, rich gravy and creamy New York-style cheesecake. Happy holiday food unfortunately can send blood cholesterol levels sky high.</description>
     <link>http://www.physorg.com/news150730240.html</link>
	 <category>Chemistry</category>
	 <pubDate>Fri, 09 Jan 2009 13:30:40 EST</pubDate>
	 <guid isPermaLink="false">news150730240</guid>
</item>
<item>
     <title>For fats, longer may not be better</title>
   	 <description>Researchers have uncovered why some dietary fats, specifically long-chain fats, such as oleic acid (found in olive oil), are more prone to induce inflammation. Long-chain fats, it turns out, promote increased intestinal absorption of pro-inflammatory bacterial molecules called lipopolysaccharides (LPS). This study appears in the January issue of JLR.</description>
     <link>http://www.physorg.com/news150652159.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 08 Jan 2009 15:49:19 EST</pubDate>
	 <guid isPermaLink="false">news150652159</guid>
</item>


</channel>
</rss>

